Evofem Biosciences Announces Issuance Of US Patent No. 11,992,472 Covering Composition And Methods For Contraception With Phexxi Vaginal Gel
- Issuance of U.S. Patent No. 11,992,472 Further Strengthens Evofem's Intellectual Patent Portfolio --
- Newly issued patent is Evofem's fifth covering Hormone-Free "In the Moment" Contraceptive Phexxi in the United States